Company Update (NYSE:MDT): Medtronic Wins European Patent Office Ruling

[Thomson Reuters ONE] – MINNEAPOLIS – March 6, 2014 – Medtronic, Inc. (NYSE: MDT) today announced that the European Patent Office (EPO) has invalidated, in its entirety, the Edwards Lifesciences EP2055266 Spenser patent . . . → Read More: Company Update (NYSE:MDT): Medtronic Wins European Patent Office Ruling Similar Articles: Company Update: Microsoft Corporation (NASDAQ:MSFT) – Microsoft and Voxx Electronics sign patent agreement for Android devices Stock Update: Google Inc (NASDAQ:GOOG) – Cisco and Google sign patent cross-licensing agreement Medtronic Inc. (NYSE:MDT) | Edwards Lifesciences to likely get compensation from Medtronic, says Wells Fargo